2025 Annual LCTRC Symposium
The Louisville Clinical & Translational Research Center will host its second annual symposium, Empowering the Future of Research, on October 14, 2025.
2025 Annual LCTRC Symposium
October 14, 2025 | 10:00 am to 1:00 pm | UofL Clinical & Translational Research Building
Join your colleagues at this year's Annual Symposium held during Research!Louisville week.
In this half-day symposium, you will connect with peers, learn about current trends in clinical research, and discover new programs offered by the LCTRC. You'll also hear from Presidential Scholars, the next generation of research leaders at UofL.
We are honored to feature a keynote address from Dr. Sally Hodder, a nationally recognized leader and the Associate Vice President for Clinical and Translational Science and Director of the WVCTSI.
Come network and enjoy lunch from Farm to Fork. CEUs are available.
View the Schedule
10:00AM - 10:20AM | LCTRC Opportunities For Researchers & Scientists
Welcome Kenneth Palmer, PhD & Maxwell Boakye MD
Bioinnovation at UofL In Kim, MD & Ted Smith, PhD
10:20AM - 11:50AM | Presidential Scholars: Research Showcase
Akshitkumar Mistry MD, Dexamethasone: Friend or Foe for Brain Tumor Patients?
Christie Buonpane MD, Harnessing Microbial Metabolite Analogs: Urolithin A as a Preventative and Therapeutic Avenue for Necrotizing Enterocolitis
Clarissa Ong PhD, Personalizing Psychological Treatment from a Process-Based Lens
Andrew Lynn PhD, Investigating Attention-Perception Interactions in Typical and Atypical Development
Frederick Ekuban PhD, Environmental Pollutants as Hidden Risk Modifiers of Alcohol-Associated Liver Disease Severity: Mechanistic & Translational Insightss
Neal Bhutiani MD-PhD, Leveraging the IL-17-gdT-Neutrophil Axis to Improve Immunotherapy in Colorectal Cancer
11:50AM - Noon | Break Lunch Farm to Fork
Noon - 1:00PM | Keynote: Sally Hodder, MD
Dr. Sally Hodder is an infectious diseases physician with extensive experience in both academia and the pharmaceutical industry. She currently serves as the Director of the West Virginia Clinical and Translational Science Institute (WVCTSI) and is the Associate Vice President for Clinical and Translational Research at West Virginia University.
Throughout her career, Dr. Hodder has focused on translational research, aiming to translate scientific discoveries into tangible health improvements, particularly for underserved rural populations. Her work has a special emphasis on HIV treatment and prevention, especially among women. She has also led initiatives related to long COVID, addiction, and lung and heart health.
In 2024, Dr. Hodder was elected to the National Academy of Medicine, becoming the first person from West Virginia University to receive this honor. She is a recognized leader in her field, having authored numerous scientific papers and book chapters, and has served on national committees, including the Council of the National Institutes of Allergy and Infectious Diseases.
Lunch by registration only.
